Atea Pharmaceuticals (AVIR) Shares Outstanding (2019 - 2026)

Atea Pharmaceuticals' Shares Outstanding history runs 8 years deep, the most recent figure standing at $80.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding fell 6.49% year-over-year to $80.0 million; the TTM figure through Mar 2026 stood at $80.0 million (down 6.49% YoY), while the FY2025 annual figure was $78.1 million, down 7.5% from the prior year.
• Shares Outstanding was $80.0 million for Q1 2026 at Atea Pharmaceuticals, up from $78.1 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $85.6 million in Q1 2025 to a low of $78.1 million in Q3 2025.
• Historically, Shares Outstanding has averaged $82.8 million across 5 years, with a median of $83.4 million in 2023.
• Biggest YoY gain for Shares Outstanding was 1.61% in 2025; the steepest drop was 7.5% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $83.3 million in 2022, then advanced by 0.18% to $83.4 million in 2023, then rose by 1.23% to $84.5 million in 2024, then decreased by 7.5% to $78.1 million in 2025, then advanced by 2.43% to $80.0 million in 2026.
• The last three Shares Outstanding figures came in at $80.0 million (Q1 2026), $78.1 million (Q4 2025), and $78.1 million (Q3 2025), per Business Quant data.